2016 ISHLT Annual Meeting and Scientific Sessions

Apr 27, 2016 ‐ Apr 30, 2016


Standard: $250.00

Sessions

PRE-MEETING SYMPOSIUM 06: Back to the Future: Cell Therapy for Thoracic Organ Failure and Transplant? -- Case Presentation: Back to the Future - Real Life Example of Cell Therapy and Tolerance in Lung Transplantation

Apr 27, 2016 9:40am ‐ Apr 27, 2016 9:45am

Identification: PMSY06f

This session will focus on cutting edge therapies that involve cells. There will be a focus on using cells to repair or fully regenerate a failing organ, for transplant tolerance induction or treatment of chronic rejection.

Speaker(s):

PRE-MEETING SYMPOSIUM 07: The Future is Here: Emerging Issues in Infectious Disease -- The Coming Apocalypse: Resistant Gram negatives, B cepaciae, Achromobacter, Stenotrophomonas

Apr 27, 2016 9:40am ‐ Apr 27, 2016 9:55am

Identification: PMSY07f

This symposium will explore the emergence and resurgence of difficult to treat pathogens in thoracic transplant and MCSD patients that challenge practitioners worldwide.

Speaker(s):

PRE-MEETING SYMPOSIUM 03: Current Innovations and Future of EVLP -- DEBATE: My Clinical Program Needs an EVLP Service (CON)

Apr 27, 2016 9:50am ‐ Apr 27, 2016 10:00am

Identification: PMSY03g

This symposia will explore the prospect of gene, cell, drug and molecular interventions during EVLP to improve outcomes for lung transplant recipients. How essential EVLP is to the running of a modern day program will be debated.

Speaker(s):

PRE-MEETING SYMPOSIUM 08: Joint ISHLT-ICCAC MCS Symposium: Joined at the Heart - International Perspectives on MCS Issues -- Coordinator Perspective: Characteristics of a Successful MCS Program

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:30am

Identification: PMSY08a

This session will discuss questions frequently asked by MCS Teams around the world regarding program structure, practice guidelines, international variations in care delivery from a program perspective, and challenges faced by patients, families and staff caring for them.

Speaker(s):

PRE-MEETING SYMPOSIUM 09: Donor Heart Selection: Strategies to Improve Organ Utilization -- US and European Donor Management Consensus Conferences: Key Messages to Improve Heart and Lung Utilization

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:35am

Identification: PMSY09a

This symposium will focus on strategies to improve organ utilization in heart transplantation. Since lack of donor organs and appropriate donor management guidelines is a pressing problem worldwide, it will be of great importance to have a symposium dedicated to delivering the outcomes of two recent consensus conferences in this area.

Speaker(s):
  • Kiran Khush, MD, MAS, Stanford University, Stanford, CA, United States

PRE-MEETING SYMPOSIUM 10: Joint ISHLT/ESC Symposium: Left, Right, and Together: The Facts and Future of PH in Left Heart Disease -- Pulmonary Hypertension-Left Heart Disease: Defining Group 2 PH

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:35am

Identification: PMSY10a

This session will explore the role of the pulmonary circulation in heart failure from left heart disease. It will discuss the interdependence of the right and left heart as well as diagnostic strategies and treatments. It is a joint session with the European Society of Cardiology Working Group of the Right Ventricle and the Pulmonary Circulation, (in collaboration with the ISHLT Scientific Council on PH and the ESC RV/Pulmonary Circulation Working Group).

Speaker(s):

PRE-MEETING SYMPOSIUM 11: Multiorgan Transplantation for Lung Recipients: When is Two Better than One? -- Heart-Lung Transplantation is Dead - The Right Ventricle Will Remodel

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:30am

Identification: PMSY11a

Referrals for multi-organ transplantation have increased as patients accumulate more complex comorbidities and those considered for re-transplantation have acquired renal disease. This session will evaluate the indications, benefits, disadvantages and challenges of performing multi-organ transplantation in patients with advanced lung disease. This will include how organ allocation policies differ in this group of potential recipients.

Speaker(s):

PRE-MEETING SYMPOSIUM 12: It's All in the Translation: CMV from Bedside to Bench and Back Again -- Be Still My Heart: CMV and CAV

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:35am

Identification: PMSY12a

This session seeks to evaluate the latest epidemiologic studies in CMV, new antiviral agents, and understanding the effective immune response to CMV. These effects range from direct organ-specific disease, to the burden of potentially toxic drug use, to indirect effects on the graft including CLAD and cardiac allograft vasculopathy.

Speaker(s):

PRE-MEETING SYMPOSIUM 13: Child's Play: Infectious Risk After Transplant During Everyday Life -- Isolation - So Old Hat!

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:30am

Identification: PMSY13a

This session addresses commonly encountered situations in the care of thoracic transplant recipients that place them at increased risk of infection. Audience will be invited to participate using an electronic response system.

Speaker(s):

PRE-MEETING SYMPOSIUM 14: Genomics: What Do I Have to Know and How Will It Affect My Practice? -- Genomics: A Crash Course

Apr 27, 2016 10:15am ‐ Apr 27, 2016 10:45am

Identification: PMSY14a

This session will provide an introduction to genomics and will discuss it's application in the care of thoracic transplant patients. The session will highlight the need for development of nursing competencies related to genomics.

Speaker(s):
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content